You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Colorcon
McKesson
Medtronic
Merck

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

RIBAVIRIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ribavirin, and when can generic versions of Ribavirin launch?

Ribavirin is a drug marketed by Aurobindo Pharma, Chartwell Rx, Teva, Zydus Pharms Usa, Navinta Llc, Beximco Pharms Usa, Heritage Pharma, Kadmon Pharms Llc, and Sandoz. and is included in eleven NDAs.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ribavirin profile page.

US ANDA Litigation and Generic Entry Outlook for Ribavirin

A generic version of RIBAVIRIN was approved as ribavirin by ZYDUS PHARMS USA on October 28th, 2005.

  Start Trial

Drug patent expirations by year for RIBAVIRIN
Drug Prices for RIBAVIRIN

See drug prices for RIBAVIRIN

Recent Clinical Trials for RIBAVIRIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 2/Phase 3
Mansoura UniversityPhase 3
Bangladesh Medical Research Council (BMRC)Phase 2/Phase 3

See all RIBAVIRIN clinical trials

Pharmacology for RIBAVIRIN
Medical Subject Heading (MeSH) Categories for RIBAVIRIN
Paragraph IV (Patent) Challenges for RIBAVIRIN
Tradename Dosage Ingredient NDA Submissiondate
VIRAZOLE FOR SOLUTION;INHALATION ribavirin 018859 2014-05-22
REBETOL CAPSULE;ORAL ribavirin 020903

US Patents and Regulatory Information for RIBAVIRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma RIBAVIRIN ribavirin CAPSULE;ORAL 079117-001 Sep 17, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa RIBAVIRIN ribavirin TABLET;ORAL 077094-004 Apr 18, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Beximco Pharms Usa RIBAVIRIN ribavirin TABLET;ORAL 202546-001 Aug 12, 2014 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa RIBAVIRIN ribavirin CAPSULE;ORAL 077224-001 Oct 28, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Merck
AstraZeneca
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.